Dec 06 2024 This Week in Cardiology

Dec 06 2024 This Week in Cardiology

Up next

Oct 30 2026 This Week in Cardiology

The ASPIRED syncope RCT, two studies in coronary artery calcium scoring, and the LEAP-Block trial of CSP vs RV pacing are the topics John Mandrola, MD, discusses in this week’s podcast.This podcast is intended for healthcare professionals only.To read a partial transcript or to c ...  Show more

Oct 23, 2026 This Week in Cardiology Podcast

Listener feedback on the nonobstructive HCM trials, AI-enhanced visits, timing of non-culprit PCI in STEMI, new tricuspid valve intervention, and EP at a crossroads are the topics John Mandrola, MD, discusses in this week’s podcast.This podcast is intended for healthcare professi ...  Show more

Recommended Episodes

Obesity Rx: How to Use New Medications in Clinic
Medscape InDiscussion: Obesity

Drs Robert Kushner and obesity pharmacotherapy expert Ania Jastreboff discuss how to use the new obesity medications effectively in clinic. Tune in to hear expert recommendations on patient communication, side effects, and more. Relevant disclosures can be found with the episode ...  Show more

408. Journal Club: The SUMMIT Trial with Dr. Milton Packer
Cardionerds: A Cardiology Podcast

Join CardioNerds Heart Failure Section Chair Dr. Jenna Skowronski, episode lead Dr. Merna Hussein, and expert faculty Dr. Milton Packer as they discuss the SUMMIT trial. The SUMMIT trial randomized 731 patients with HFpEF with LVEF ≥ 50% and obesity with BMI ≥ 30 kg/m2 to receive ...  Show more

Semaglutide & Tirzepatide Updates at ESC Congress 2025
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

At ESC 2025, a pair of presentations highlighted the ongoing debate over cardiovascular risk reduction with semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound), yielding conflicting signals that clinicians will need to interpret carefully. In this special edition epi ...  Show more